Revolution Medicines, Inc. (RVMD) Shareholders’ equity 2018–2025
Revolution Medicines, Inc. (RVMD) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.6BFY2025 · since FY2018: -$108.4M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | -28.0% |
| FY2024 | $2.3B | +24.0% |
| FY2023 | $1.8B | +166.5% |
| FY2022 | $685.2M | +13.7% |
| FY2021 | $602.6M | +26.9% |
| FY2020 | $474.7M | +411.1% |
| FY2019 | -$152.6M | -40.7% |
| FY2018 | -$108.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice